| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $991K | — | -18.1% |
| Cost of Revenue | $363K | — | +1.4% |
| Gross Profit | $628K | — | -26.3% |
| R&D Expense | $348K | — | +23.4% |
| SG&A Expense | $2.9M | — | +13.9% |
| Operating Income | -$2.6M | — | -32.7% |
| Net Income | -$2.7M | — | -406.5% |
| EPS (Basic) | -$0.58 | — | -5.5% |
| EPS (Diluted) | -$0.58 | — | -5.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $593K | -54.3% | -89.9% |
| Accounts Receivable | $75K | -26.5% | -53.1% |
| Inventory | $605K | +61.8% | -41.7% |
| Current Assets | $1.5M | -29.8% | -79.1% |
| Total Assets | $2.6M | -20.1% | -68.0% |
| Current Liabilities | $3.7M | +58.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.1M | — | +30.0% |
| Capital Expenditures | $87K | — | -33.6% |
| Investing Cash Flow | -$87K | — | +33.6% |
| Financing Cash Flow | $477K | — | +667.9% |
| Free Cash Flow | -$1.2M | — | +30.3% |
| +83.4% |
| Total Liabilities | $4.2M | +75.2% | +104.6% |
| Stockholders' Equity | -$1.5M | -264.3% | -124.5% |